Press-release for stocks for teva pharmaceutical industries ltd

Prices are updated after-hours

Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Teva pharmaceutical industries ltd crawled time : 08:00

save search

Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published: 2023-12-08 (Crawled : 08:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K

|

Health Technology

| -21.02% | O: -2.79% H: 0.62% C: 0.62%
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| 2.34% | O: 2.06% H: 0.82% C: 0.82%
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| -3.34% | O: -1.29% H: 0.4% C: 0.4%
ALPMY | $9.47 -1.11% 520K

|

| -22.51% | O: -2.2% H: 0.0% C: -0.27%
TAK | News | $13.24 0.61% 0.0% 1.3M

|

Health Technology

| -5.97% | O: -0.64% H: 0.5% C: 0.5%
NVO | News | $122.71 -0.03% 0.17% 5M

|

Health Technology

| 26.75% | O: -0.42% H: 0.67% C: 0.25%
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| -1.64% | O: 0.19% H: 0.35% C: 0.2%
JNJ | News | $147.91 1.49% -0.03% 9.6M

|

Health Technology

| -5.17% | O: -0.18% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M

|

Health Technology

| 23.82% | O: 0.43% H: 0.0% C: 0.0%
BMY | $48.93 1.3% 0.0% 10M

|

Health Technology

| -2.45% | O: 0.2% H: 0.55% C: 0.1%
ABBV | $166.41 1.06% 0.0% 5.5M

|

Health Technology

| 12.6% | O: 0.3% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| 1.27% | O: 1.07% H: 0.0% C: 0.0%
GILD | $66.77 0.92% 0.91% 11M

|

Health Technology

| -14.47% | O: 0.08% H: 1.45% C: 1.17%
AMGN | $269.03 2.39% 2.33% 3.4M

|

Health Technology

| -0.88% | O: -0.05% H: 0.3% C: -0.76%
reach market

Teva Phase IV UNITE Study Shows AJOVY® (fremanezumab) Reduced Migraine Attacks and Depression Symptoms in Migraine Sufferers with Major Depressive Disorder
Published: 2023-10-17 (Crawled : 08:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M

|

Health Technology

| 47.14% | O: -0.69% H: 1.27% C: -0.23%
ajovy depression teva migraine study

Alvotech Provides Update on Status of U.S. Biologics License Application for AVT04
Published: 2023-10-12 (Crawled : 08:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M

|

| 45.27% | O: -0.22% H: 0.0% C: -0.66%
JNJ | News | $147.91 1.49% -0.03% 9.6M

|

Health Technology

| -6.8% | O: -1.87% H: 0.0% C: 0.0%
KMDA | News | $5.05 -0.98% -0.99% 27K

|

Health Technology

| 5.06% | O: -0.51% H: 0.1% C: -1.32%
avt04 license update application

Antibacterial Drugs Market to grow by USD 9.90 billion from 2022 to 2027 | Asia to account for 42% of market growth- Technavio
Published: 2023-10-04 (Crawled : 08:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

|

Health Technology

| 15.03% | O: 1.69% H: 0.8% C: 0.8%
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| 13.75% | O: 17.72% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| -5.13% | O: -3.27% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M

|

Health Technology

| 10.76% | O: 0.81% H: 0.19% C: -0.28%
ABBV | $166.41 1.06% 0.0% 5.5M

|

Health Technology

| 12.58% | O: -0.89% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -13.13% | O: 1.07% H: 0.0% C: 0.0%
antibacterial asia market

Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease Treatment
Published: 2023-10-04 (Crawled : 08:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M

|

Health Technology

| 33.96% | O: 1.46% H: 0.21% C: -5.65%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -13.13% | O: 1.07% H: 0.0% C: 0.0%
disease treatment collaboration teva sanofi

Alvotech Announces Approval in Japan of AVT04 (ustekinumab), a Biosimilar to Stelara®
Published: 2023-09-25 (Crawled : 08:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M

|

| 48.87% | O: 1.24% H: 4.25% C: -0.67%
KMDA | News | $5.05 -0.98% -0.99% 27K

|

Health Technology

| 0.39% | O: 1.16% H: 1.98% C: -0.38%
avt04 stelara biosimilar japan approval

Female Sexual Dysfunction Treatment Market to grow by USD 7.76 billion from 2022-2027; North America to account for 61% of market growth - Technavio
Published: 2023-09-11 (Crawled : 08:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 3.4K

|

| -60.0% | O: 0.0% H: 10.0% C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M

|

Health Technology

| 11.28% | O: 0.4% H: 0.69% C: -1.38%
america treatment growth market

Alvotech Completes $100 Million Convertible Bond Private Placement
Published: 2023-07-31 (Crawled : 08:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M

|

| 34.9% | O: 0.0% H: 5.0% C: 0.0%
KMDA | News | $5.05 -0.98% -0.99% 27K

|

Health Technology

| 4.85% | O: 0.0% H: 1.82% C: -0.4%

Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership
Published: 2023-07-24 (Crawled : 08:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M

|

| 33.54% | O: 5.05% H: 2.26% C: -3.17%
JNJ | News | $147.91 1.49% -0.03% 9.6M

|

Health Technology

| -13.09% | O: 0.77% H: 1.35% C: -0.24%
KMDA | News | $5.05 -0.98% -0.99% 27K

|

Health Technology

| 1.76% | O: -0.59% H: 1.18% C: -0.97%
partnership update pharmaceuticals teva

Complete Response Letter Received for AVT02 Biologics License Application
Published: 2023-04-14 (Crawled : 08:00) - biospace.com/
ALVO | News | $13.23 2.64% 2.57% 1.7M

|

| -3.43% | O: -14.46% H: 0.0% C: -8.97%
TEVA | $12.86 0.63% 0.0% 10M

|

Health Technology

| 38.88% | O: -7.13% H: 1.05% C: -3.6%
avt02 license application response

Ewing's Sarcoma Treatment Market size to grow by USD 302.5 million from 2021 to 2026, Driven by the growing awareness about and funding for Ewing's sarcoma - Technavio
Published: 2023-04-12 (Crawled : 08:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

|

Health Technology

| 8.02% | O: 1.63% H: 0.0% C: -2.39%
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| 17.97% | O: 1.1% H: 0.0% C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M

|

Health Technology

| 13.52% | O: 0.71% H: 0.3% C: -1.6%
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| -1.5% | O: 0.75% H: 0.5% C: -0.05%
GSK | News | $39.75 1.22% 0.0% 1.6M

|

Health Technology

| 6.43% | O: 1.15% H: 0.39% C: -0.19%
BAX | $39.47 -0.45% 0.0% 2.8M

|

Health Technology

| -7.97% | O: 0.47% H: 0.8% C: -0.97%
BHC | $8.69 1.05% 0.0% 2.9M

|

Health Technology

| 14.04% | O: 1.31% H: 0.26% C: -4.4%
treatment growing funding market

Testosterone replacement therapy market: North America to account for 58% of market growth, Driven by initiatives to increase awareness about hypogonadism among the population - Technavio
Published: 2023-02-17 (Crawled : 08:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 3.4K

|

| -95.58% | O: 1.55% H: 3.26% C: 2.93%
VTRS A | $11.25 1.17% 1.16% 4.7M

|

Health Technology

| -3.43% | O: -1.03% H: 2.08% C: 1.39%
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| 9.77% | O: -0.24% H: 1.61% C: 1.52%
ABBV | $166.41 1.06% 0.0% 5.5M

|

Health Technology

| 11.29% | O: -0.25% H: 1.5% C: 1.45%
america therapy market

Mild Cognitive Impairment (MCI) Treatment Market to Experience Substantial CAGR Growth of 8.7% by 2029, Size, Share, Trends, Key Drivers, Growth and Opportunity Analysis
Published: 2023-02-16 (Crawled : 08:00) - prnewswire.com
UCBJY | $63.676 -4.38% 7.2K

|

| 54.93% | O: -1.68% H: 0.0% C: -0.76%
VTRS A | $11.25 1.17% 1.16% 4.7M

|

Health Technology

| -5.06% | O: -1.1% H: 0.21% C: -0.6%
TAK | News | $13.24 0.61% 0.0% 1.3M

|

Health Technology

| -15.45% | O: -0.89% H: 0.71% C: 0.26%
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| 8.24% | O: -1.48% H: 0.55% C: 0.08%
JNJ | News | $147.91 1.49% -0.03% 9.6M

|

Health Technology

| -7.19% | O: -0.19% H: 0.36% C: -0.52%
treatment growth market

EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
Published: 2023-02-09 (Crawled : 08:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M

|

| 1.61% | O: 7.61% H: 0.0% C: -4.64%
JNJ | News | $147.91 1.49% -0.03% 9.6M

|

Health Technology

| -9.6% | O: 0.01% H: 0.71% C: -1.36%
KMDA | News | $5.05 -0.98% -0.99% 27K

|

Health Technology

| 17.95% | O: -0.23% H: 0.25% C: -2.05%
avt04 stelara biosimilar ema application

Alvotech Announces Australian Marketing Authorization for AVT02, a Biosimilar to Humira®
Published: 2022-11-14 (Crawled : 08:00) - biospace.com/
ALVO | News | $13.23 2.64% 2.57% 1.7M

|

| 113.57% | O: 8.39% H: 1.65% C: -1.78%
KMDA | News | $5.05 -0.98% -0.99% 27K

|

Health Technology

| 15.33% | O: 0.0% H: 1.78% C: -1.78%
avt02 humira biosimilar authorization

Male Hypogonadism Market Size to Grow by USD 684.95 Mn, AbbVie Inc. and Bayer AG Among Key Vendors - Technavio
Published: 2022-09-19 (Crawled : 08:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M

|

Health Technology

| 15.51% | O: -0.29% H: 0.15% C: -0.68%
LPCN | $5.33 -2.02% -2.06% 11K

|

Health Technology

| -45.33% | O: -1.23% H: 3.57% C: -0.54%
market

Celiac Diseases Drugs Market Report by Technavio expects growth to accelerate at 16.95% CAGR
Published: 2022-09-12 (Crawled : 08:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

|

Health Technology

| 28.87% | O: -4.56% H: 9.43% C: 7.62%
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| 16.35% | O: -0.78% H: 0.58% C: 0.58%
GSK | News | $39.75 1.22% 0.0% 1.6M

|

Health Technology

| 24.65% | O: 1.44% H: 1.67% C: 0.31%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| 13.82% | O: 1.6% H: 0.0% C: 0.0%
BLRX | $0.6564 2.55% 2.48% 190K

|

Health Technology

| -63.74% | O: -3.3% H: 1.7% C: -6.82%
AMGN | $269.03 2.39% 2.33% 3.4M

|

Health Technology

| 8.58% | O: -3.91% H: 1.55% C: -0.16%
report growth market

Studies Show Effectiveness of AJOVY®▼ (fremanezumab) for Treatment of Migraine in Patients With Co-morbid Depression
Published: 2022-09-08 (Crawled : 08:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M

|

Health Technology

| 45.48% | O: -0.45% H: 2.95% C: 2.27%
ajovy treatment migraine depression

European Commission grants marketing authorization for Ranivisio▼®* (ranibizumab), a biosimilar to Lucentis®**, for age-related macular degeneration (AMD) the most common cause of blindness in developed countries
Published: 2022-08-29 (Crawled : 08:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M

|

Health Technology

| 34.1% | O: -1.36% H: 0.48% C: -0.63%
lucentis biosimilar macular grants authorization

Antibiotic Production Market Destine to Reach USD 61.29 Billion, Size, Share, Industry Growth Rate, Demand & Revenue Forecast By 2029
Published: 2022-07-29 (Crawled : 08:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| -4.59% | O: 4.3% H: 0.0% C: -0.39%
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| 8.14% | O: -0.95% H: 0.0% C: -0.69%
JNJ | News | $147.91 1.49% -0.03% 9.6M

|

Health Technology

| -14.71% | O: 0.25% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -8.5% | O: -1.23% H: 0.0% C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M

|

Health Technology

| 7.68% | O: -0.52% H: 0.45% C: -0.4%
growth market

← Previous
1
2
Next →

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M

|

EGOX | $0.0515 43.06% 30.1% 330M

|

OLB 4 | $0.33 -14.95% 25.53% 840K

|

Technology Services

NVFY | $2.77 31.28% 23.83% 33M

|

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M

|

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M

|

Distribution Services

INSG | $3.03 25.21% 20.13% 330K

|

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K

|

WLGS | $0.59 18.0% 17.9% 2.3M

|

ASNS | $0.828 21.75% 17.86% 18K

|

Your saved searches

Save your searches and get alerts when important news are released.